Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Alphabet (Google) Class C
GOOG
|
$831M |
| 2 |
Palo Alto Networks
PANW
|
$348M |
| 3 |
Visa
V
|
$347M |
| 4 |
Citigroup
C
|
$296M |
| 5 |
CELG
Celgene Corp
CELG
|
$295M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$638M |
| 2 |
EOG Resources
EOG
|
$322M |
| 3 |
Canadian Pacific Kansas City
CP
|
$305M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$289M |
| 5 |
JD.com
JD
|
$283M |
Sector Composition
| 1 | Healthcare | 19.11% |
| 2 | Consumer Discretionary | 17.28% |
| 3 | Communication Services | 14.32% |
| 4 | Technology | 13.24% |
| 5 | Financials | 10.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
701
ArcelorMittal
MT
$26B
| $253K | ﹤0.01% |
21,495
-66,870
| -76% | -$787K |
|
|
GG
702
DELISTED
Goldcorp Inc
GG
| $250K | ﹤0.01% |
19,936
-62,022
| -76% | -$778K |
|
703
Sally Beauty Holdings
SBH
$1.44B
| $241K | ﹤0.01% |
+10,163
| New | +$241K |
|
|
WUBA
704
DELISTED
58.COM INC
WUBA
| $230K | ﹤0.01% |
+4,892
| New | +$230K |
|
|
GNVC
705
DELISTED
GenVec, Inc.
GNVC
| $227K | ﹤0.01% |
9,837
| – | – |
|
|
CBPO
706
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $215K | ﹤0.01% |
2,397
| – | – |
|
|
SPNC
707
DELISTED
Spectranetics Corp
SPNC
| $213K | ﹤0.01% |
18,080
-723,674
| -98% | -$8.53M |
|
708
HDFC Bank
HDB
$361B
| $201K | ﹤0.01% |
+6,580
| New | +$201K |
|
|
NVTA
709
DELISTED
Invitae Corporation
NVTA
| $190K | ﹤0.01% |
26,344
+83
| +0.3% | +$599 |
|
710
Accenture
ACN
$159B
| – | – |
-16,190
| Closed | -$1.57M |
|
711
Archer Daniels Midland
ADM
$30.2B
| – | – |
-70,603
| Closed | -$3.4M |
|
712
Akamai
AKAM
$11.3B
| – | – |
-14,531
| Closed | -$1.02M |
|
713
Alaska Air
ALK
$7.28B
| – | – |
-17,814
| Closed | -$1.15M |
|
714
Amgen
AMGN
$153B
| – | – |
-23,445
| Closed | -$3.6M |
|
715
Ameriprise Financial
AMP
$46.1B
| – | – |
-29,348
| Closed | -$3.67M |
|
716
Ashland
ASH
$2.51B
| – | – |
-13,705
| Closed | -$817K |
|
717
Franklin Resources
BEN
$13B
| – | – |
-71,329
| Closed | -$3.5M |
|
718
Bunge Global
BG
$16.9B
| – | – |
-1,550,275
| Closed | -$136M |
|
719
Baidu
BIDU
$35.1B
| – | – |
-1,172
| Closed | -$233K |
|
720
CrossAmerica Partners
CAPL
$784M
| – | – |
-120,445
| Closed | -$3.41M |
|
721
Caterpillar
CAT
$198B
| – | – |
-14,228
| Closed | -$1.21M |
|
722
Canadian Natural Resources
CNQ
$63.2B
| – | – |
-116,072
| Closed | -$1.52M |
|
723
Esperion Therapeutics
ESPR
$540M
| – | – |
-70,720
| Closed | -$5.78M |
|
724
Evolent Health
EVH
$1.11B
| – | – |
-49,826
| Closed | -$972K |
|
725
Evercore
EVR
$12.3B
| – | – |
-7,416
| Closed | -$400K |
|